Your browser doesn't support javascript.
loading
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.
Tong, Chuan; Zhang, Yajing; Liu, Yang; Ji, Xingyu; Zhang, Wenying; Guo, Yelei; Han, Xiao; Ti, Dongdong; Dai, Hanren; Wang, Chunmeng; Yang, Qingming; Liu, Wanli; Wang, Yao; Wu, Zhiqiang; Han, Weidong.
Afiliación
  • Tong C; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Zhang Y; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Liu Y; Department of Bio-therapeutic, The First Medical Center, Chinese PLA General Hospital, Beijing, China; and.
  • Ji X; Ministry of Education Key Laboratory of Protein Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Institute for Immunology, Tsinghua University, Beijing, China.
  • Zhang W; Department of Bio-therapeutic, The First Medical Center, Chinese PLA General Hospital, Beijing, China; and.
  • Guo Y; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Han X; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Ti D; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Dai H; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Wang C; Department of Bio-therapeutic, The First Medical Center, Chinese PLA General Hospital, Beijing, China; and.
  • Yang Q; Department of Bio-therapeutic, The First Medical Center, Chinese PLA General Hospital, Beijing, China; and.
  • Liu W; Ministry of Education Key Laboratory of Protein Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Institute for Immunology, Tsinghua University, Beijing, China.
  • Wang Y; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Wu Z; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
  • Han W; Department of Molecular Biology and Immunology, Institute of Basic Medicine and.
Blood ; 136(14): 1632-1644, 2020 10 01.
Article en En | MEDLINE | ID: mdl-32556247
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD20 / Antígenos CD19 / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD20 / Antígenos CD19 / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article